Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.12 -4.88%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $23.00 (from $20.00) while maintaining a Perform rating.
You May Also Be Interested In
- Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)
- Citi Upgrades Osotspa (OSP:TB) (OSOPF) to Buy
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
